Chopra’s dissent: The Tipline for 23 October 2018
FTC commissioner Rohit Chopra yesterday objected to his agency’s approval of the Linde/Praxair merger, criticising the agreed remedies for failing to protect competition. We also have a litigator of the week piece honouring a team at White & Case that convinced an appellate court to overturn a decision certifying a class of plaintiffs in a claim against Allergan.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10